Company intelligence / Profile preview

Vella Bioscience

Worcester, Massachusetts, United Statesvellabio.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

Vella's flagship product is a clinically demonstrated nano-encapsulated topical lotion designed for women seeking easier, more intense, and more frequent orgasms. It is the first and only lotion that relaxes vaginal smooth muscle to enhance sexual response[4].

Therapeutic areas: Women's Health
Modalities: Topical CBD formulationsNano-encapsulated topical lotions
Industry: Biotech

Drug pipeline

3 assets

FX-1610

Pre-clinical

Indications: Acute lymphoblastic leukemia

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Vella Bioscience.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vella Bioscience.

Explore the full profile